Back
Autolus Therapeutics PLC 10K Form
Buy
59
AUTL
Autolus Therapeutics PLC
Last Price:
3.33
Seasonality Move:
-10.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AUTL News And Ratings
See the #1 stock for the next 7 days that we like better than AUTL
AUTL Financial Statistics
Sales & Book Value
| Annual Sales: | $1.7M |
|---|---|
| Cash Flow: | $-51.92M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.98 |
| Price / Book: | 1.77 |
Profitability
| EPS (TTM): | -1.17000 |
|---|---|
| Net Income (TTM): | $-233.98M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Autolus Therapeutics PLC Earnings Forecast
Key Autolus Therapeutics PLC Financial Ratios
- The Research & Development expenses have been 7,684.39% of Revenue.
- The Interest Expense is -21.63% of Operating Income.
- The Net Earning history of AUTL is -12,272.26% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 5 years.
Autolus Therapeutics PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AUTL |
| CUSIP: | 05280R |
| Website: | autolus.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AUTL Technical Analysis vs Fundamental Analysis
Buy
59
Autolus Therapeutics PLC (AUTL)
is a Buy
Is Autolus Therapeutics PLC a Buy or a Sell?
-
Autolus Therapeutics PLC stock is rated a Buy
The current Autolus Therapeutics PLC [AUTL] share price is $3.51. The Score for AUTL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.